Our Work

Our Center’s work links policy analysis with policy engagement to address critical challenges in the organization, financing, and delivery of global health. Our research focuses particularly on:

  • The financing of global public goods for health, such as research and development for poverty-related and neglected diseases
  • The value of investing in health, including investments in health innovation
  • The four major health transitions that middle-income countries are navigating: shifts in diseases, demography, development assistance for health, and domestic health financing (the “4D’s” of global health transition).
Click here to view our current projects. Featured projects include:

The global health landscape is undergoing a set of rapid and profound transitions that threaten to stall or even derail progress in global health improvement. The 4Ds project analyzes four of these major, inter-linked transitions—shifts in diseases, demography, development assistance for health (DAH), and domestic health financing. Learn more…

This project is studying the health and financial benefits of public investments in reproductive, maternal, newborn, adolescent, and child health (RMNACH). Learn more…

In March 2018, the government of India approved a publicly funded health insurance scheme that is officially called the Prime Minister (or Pradhan Mantri) Jan Arogya Yojana (PM-JAY), also known as Ayushman Bharat (and known colloquially as “Modicare” after Indian Prime Minister Narendra Modi). With funding from a Duke Global Health Institute pilot grant, the Center for Policy Impact in Global Health is conducting a mixed methods study on the implementation and financing of PM-JAY in Uttar Pradesh. Learn more…

In 2018, a research team from Duke University and Policy Cures Research, in collaboration with TDR, the Special Programme for Research and Training in Tropical Diseases, published the first analysis of the pipeline of products for poverty-related neglected tropical diseases (PRNTDs) using a financial modelling tool called Portfolio-to-Impact (P2I). The analysis summarized the pipeline of candidate products for PRNTDs and estimated (a) the costs to move these candidates through the pipeline, (b) the likely launches, and (c) the additional costs to launch critical “missing” products.  In a new project, the Center is partnering with Policy Cures Research to update both the pipeline portfolio review and the cost modeling. Learn more…

Questions? Please contact Heather Hille.

To stay up to date on our work subscribe to our mailing list.